Skip to main content
Clinical Trials/NCT03711045
NCT03711045
Unknown
Not Applicable

An Eye Tracking Study of Affective Disorder Patients With Suicide Risk

Central South University1 site in 1 country200 target enrollmentSeptember 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Major Depressive Disorder
Sponsor
Central South University
Enrollment
200
Locations
1
Primary Endpoint
eye movement performance during free-view task
Last Updated
7 years ago

Overview

Brief Summary

This research tries to investigate the validity and reliability of eye-tracking technologies by using different paradigms (eg. free-view, pro-saccade and anti-saccade) which served as a novel way of evaluating suicide risk among affective disorder patients including bipolar and unipolar depression. All the participants including health control will be assessed by clinical interviewing, self-report assessment, cognitive evaluation and eye-tracking task.

Registry
clinicaltrials.gov
Start Date
September 1, 2018
End Date
December 31, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Central South University
Responsible Party
Principal Investigator
Principal Investigator

Lingjiang Li

President of Chinese Psychiatry Society of Chinese Medical Association

Central South University

Eligibility Criteria

Inclusion Criteria

  • Diagnostic and Statistical Manual,DSM-IV diagnosis of depression or Bipolar disorder
  • BDI-II\>20(Suicide and disorder control group); BDI-II\<13,no history of depression(Health control)
  • Informed consent
  • suicide attempt in the past 6 months(suicide risk group)

Exclusion Criteria

  • Current or past substance abuse, psychotic disorder,obsessive compulsive disorder , Post-Traumatic Stress Disorder, in the past 6 months
  • History of epilepsy or head trauma
  • Eye disorders
  • History of electroconvulsive therapy in the past 4 weeks.

Outcomes

Primary Outcomes

eye movement performance during free-view task

Time Frame: 1 hour

The first fixated location and latency(msec)of eah trial, the total dwell time(msec) in each interest areas(IAs) during the whole trial to assess the attentional bias in the experiment.

Secondary Outcomes

  • Scores in self-report assessment:Beck Anxiety Inventory(5 minutes)
  • Scores in self-report assessment:Beck Depression Inventory(5 minutes)
  • Scores in self-report assessment:Barratt Impulsiveness Scale(5 minutes)
  • Scores in self-report assessment:Ruminative Response Scale(5 minutes)

Study Sites (1)

Loading locations...

Similar Trials